tiprankstipranks
Nabriva Therapeutics (NBRVF)
OTHER OTC:NBRVF
US Market
NBRVF
Nabriva Therapeutics
RESEARCH TOOLSreports

Nabriva Therapeutics (NBRVF) Financial Statements

1,011 Followers

Nabriva Therapeutics Financial Overview

Nabriva Therapeutics's market cap is currently $323.00. The company's EPS TTM is $; its P/E ratio is ―; Nabriva Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 35.67M$ 27.22M$ 5.03M$ 7.75M$ 6.50M
Gross Profit$ 7.09M$ 14.07M$ 3.44M$ 7.68M$ 6.50M
Operating Income$ -55.49M$ -48.53M$ -66.13M$ -79.49M$ -114.38M
EBITDA$ -54.70M$ -47.42M$ -66.88M$ -78.72M$ -114.09M
Net Income$ -57.19M$ -49.45M$ -69.48M$ -82.76M$ -114.78M
Balance Sheet
Cash & Short-Term Investments$ 12.41M$ 47.67M$ 41.38M$ 86.19M$ 102.23M
Total Assets$ 31.77M$ 80.91M$ 58.44M$ 94.11M$ 110.42M
Total Debt$ 5.22M$ 8.03M$ 7.73M$ 34.50M$ 23.72M
Net Debt$ -7.19M$ -39.63M$ -33.63M$ -51.52M$ -78.28M
Total Liabilities$ 28.47M$ 27.56M$ 25.30M$ 52.84M$ 41.79M
Stockholders' Equity$ 3.29M$ 53.35M$ 33.13M$ 41.27M$ 68.63M
Cash Flow
Free Cash Flow$ -36.92M$ -59.58M$ -71.44M$ -71.95M$ -72.95M
Operating Cash Flow$ -36.71M$ -59.56M$ -71.33M$ -71.89M$ -72.72M
Investing Cash Flow$ -263.00K$ -81.00K$ -274.00K$ 331.00K$ -4.60M
Financing Cash Flow$ 1.85M$ 66.37M$ 26.92M$ 56.08M$ 92.92M
Currency in USD

Nabriva Therapeutics Earnings and Revenue History

Income Statement >

Nabriva Therapeutics Debt to Assets

Balance Sheet >

Nabriva Therapeutics Cash Flow

Cash Flow >

Nabriva Therapeutics Forecast EPS vs Actual EPS

Earnings >